Impact of nutritional status on serum lipoprotein (a) concentration in patients undergoing continuous ambulatory peritoneal dialysis

Peritoneal Dialysis International

Volumn 16, Issue SUPPL. 1, 1996, Pages

  Kang, Duk Hee ^a,c   Yoon, Kyun Il ^a   Lee, Seung Woo ^b   Kang, Shin Wook ^b   Choi, Kyu Hun ^b   Lee, Ho Yung ^b   Han, Dae Suk ^b  

^a Ewha Womans University School of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Ewha Womans University   (South Korea)

Author keywords

Lipoprotein (a); Nutrition

Indexed keywords

CREATININE; LIPOPROTEIN A; UREA;

ADULT; ANTHROPOMETRY; ATHEROSCLEROSIS; BIOCHEMISTRY; CLINICAL TRIAL; CONFERENCE PAPER; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CREATININE CLEARANCE; DOSE RESPONSE; FEMALE; HUMAN; LEAN BODY WEIGHT; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NUTRITION; NUTRITIONAL STATUS; PRIORITY JOURNAL; PROTEIN DEGRADATION;

EID: 0029943015     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686089601601s45     Document Type: Conference Paper

References (21)

1. Armstrong VW, Cremer P, Eberle E. The association between serum LP(a) concentration and angiographically assessed coronary atherosclerosis. Atherosclerosis 1986; 62:249-57.
2. Durrington PN, Ishola M, Hunt L, Arrol S, Bhatnagar D. Apolipoprotein (a) , A1, and B and parental history in men with early onset ischemic heart disease. Lancet 1988; 1:1070-3.
3. Berg K. A new serum type system in man: the LP system. Acta Pathol Microbiol Scand 1963; 59:369-82.
4. McBewu AD, Durrington PN. Lipoprotein (a): structure, properties and possible involvement in thrombogenesis and atherosclerosis. Atherosclerosis 1990; 85:1-14.
5. Shoji T, Nishizawa Y, Nishitani H, Yamakaya M, Morii H. High serum lipoprotein (a) concentration in urémie patients treated with continuous ambulatory peritoneal dialysis. Clin Nephrol 1992; 38 (5):271-6.
6. Thillet J, Faucher C, Issad B, Allouache M, Chapman J, Jacobs C. Lipoprotein (a) in patients treated by continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1993; 22 (1):226-32.
7. Anwar N, Bhatnagar D, Short CD, et al. Serum lipoprotein (a) concentration in patients undergoing continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 1993; 8 (1):71-4.
8. Cressman MD, Heyka RJ, Paganini EP, O'Neil J, Skibibski CI, Hoff HF. Lipoprotein (a) is an independent risk factor for cardiovascular disease in hemodialysis patients. Circulation 1992; 86:475-82.
9. Acchiardo SR, Moore LW, Latour PA. Malnutrition as a main factor in morbidity and mortality of hemodialysis patients. Kidney Int 1983; 24(Suppl 16):S199-203.
10. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein concentration in plasma without use of preparative ultracentrifuge. Clin Chem 1972; 18:499.
11. Keshaviah PR, Nolph KD, Prowant B, et al. Lean body mass estimation by creatinine kinetics. J Am Soc Nephrol 1994; 4:1475-85.
12. Heymsfield SB, McManus C, Stevens V, Smith J. Muscle mass: reliable indicator of protein-energy malnutrition severity and outcome. Am J Clin Nutr 1992; 35:1192-9.
13. Gokal R, Ramos JM, McGurk JG, Ward MK, Kerr DNS. Hyperlipidemia in patients on continuous ambulatory peritoneal dialysis. Advances in peritoneal dialysis. Amsterdam: Excerpta Medica, 1981:434-6.
14. Ramos JM, Heaton A, McGurk JG, Ward MK, Kerr DNS. Sequential changes in serum lipids and their subfraction in patients receiving continuous ambulatory peritoneal dialysis. Nephron 1983; 35:20-3.
15. Zenkeer G, Koltringer P, Bone G, Niederkorn K, Pfeiffer K, Jurgens G. Lipoprotein (a) as a strong indicator for cerebrovascular disease. Stroke 1986; 17:942-5.
16. Goldwasser P, Michel MA, Collier J, et al. Prealbumin and lipoprotein (a) in hemodialysis: relationships with patient and vascular access survival. Am J Kidney Dis 1993; 22 (1):215-25.
17. Utermann G. The mysteries of lipoprotein (a). Science 1989; 246:904-10.
18. Bergstrom J, Lindholm B. Nutrition and adequacy of dialysis. How do hemodialysis and CAPD compare? Kidney Int 1993; 34:839.
19. Black IW, Wilken DL. Decreases in apolipoprotein (a) after renal transplantation: implications for lipoprotein (a) metabolism. Clin Chem 1992; 38 (3):353-7.
20. Klempler VWF, Koster GM, Roscher A, Haslauer F, Bolzano KJ. Studies on the role of specific cell surface receptors in the removal of lipoprotein (a) in man. J Clin Invest 1980; 65:1483-90.
21. Wanner C, Bartens W, Walz G, Nauck M, Schollmeyer P. Protein loss and genetic polymorphism of apolipoprotein (a) modulate serum lipoprotein(a) in CAPD patients. Nephrol Dial Transplant 1995; 10:75-81.